找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: Anticoagulants, Antiplatelets, and Thrombolytics; Shaker A. Mousa Book 2010Latest edition Springer Science+Business Media, LLC 2010 Anti-X

[复制链接]
查看: 11851|回复: 56
发表于 2025-3-21 19:43:19 | 显示全部楼层 |阅读模式
期刊全称Anticoagulants, Antiplatelets, and Thrombolytics
影响因子2023Shaker A. Mousa
视频video
发行地址Fully updates the popular original edition with cutting-edge approaches.Provides easy-to-use, readily reproducible protocols.Includes expert tips on troubleshooting and avoiding common pitfalls.Includ
学科分类Methods in Molecular Biology
图书封面Titlebook: Anticoagulants, Antiplatelets, and Thrombolytics;  Shaker A. Mousa Book 2010Latest edition Springer Science+Business Media, LLC 2010 Anti-X
影响因子During the past decade, remarkable progress has been made in the development of newer drugs to prevent and treat thromboembolic disorders, such as oral direct anti-Xa and anti-IIa antagonists, as well as oral antiplatelet ADP antagonists with rapid onset and offset. In addition, there has been concentrated effort aimed at identifying novel uses of traditional antithrombotic drugs, such as aspirin, heparin, and oral anticoagulants, as well as combinations of agents, such as more than one antiplatelet, antiplatelet with anticoagulant, antiplatelet with or without thrombolytic.Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition provides updates on various strategies in thrombosis, experimental models, and clinical and recent advances in the discovery and development of novel antithrombotics.As a volume in the highly successful Methods in Molecular Biology™ series, this collection provides the kind of detailed description and implementation advice that is crucial for getting optimal results.Easy to use and up to date, Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition is an ideal guide for researchers aiming for the future of this vital field, focusing on the
Pindex Book 2010Latest edition
The information of publication is updating

书目名称Anticoagulants, Antiplatelets, and Thrombolytics影响因子(影响力)




书目名称Anticoagulants, Antiplatelets, and Thrombolytics影响因子(影响力)学科排名




书目名称Anticoagulants, Antiplatelets, and Thrombolytics网络公开度




书目名称Anticoagulants, Antiplatelets, and Thrombolytics网络公开度学科排名




书目名称Anticoagulants, Antiplatelets, and Thrombolytics被引频次




书目名称Anticoagulants, Antiplatelets, and Thrombolytics被引频次学科排名




书目名称Anticoagulants, Antiplatelets, and Thrombolytics年度引用




书目名称Anticoagulants, Antiplatelets, and Thrombolytics年度引用学科排名




书目名称Anticoagulants, Antiplatelets, and Thrombolytics读者反馈




书目名称Anticoagulants, Antiplatelets, and Thrombolytics读者反馈学科排名




单选投票, 共有 0 人参与投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用户组没有投票权限
发表于 2025-3-21 20:20:31 | 显示全部楼层
Oral Direct Factor Xa Inhibitors, with Special Emphasis on Rivaroxaban,treatment of pulmonary embolism, secondary prevention after acute coronary syndromes, and the prevention of stroke and non-central nervous system embolism in patients with non-valvular atrial fibrillation. The need for new oral anticoagulants, the development and pharmacology of rivaroxaban, results
发表于 2025-3-22 01:11:32 | 显示全部楼层
Prasugrel: A Novel Platelet ADP P2Y12 Receptor Antagonist,t response, and faster onset of activity compared to clopidogrel. Recent findings from large-scale phase-III testing show prasugrel to be more efficacious in preventing ischemic events in acute coronary syndrome patients undergoing percutaneous coronary intervention (PCI); however, this is achieved
发表于 2025-3-22 06:48:32 | 显示全部楼层
Adhesion Molecules: Potential Therapeutic and Diagnostic Implications,d on the key role of CAMs, with special emphasis on integrins in various diseases, as well as the structure–function aspects of cell adhesion and signaling of the different CAMs and ECM are highlighted.
发表于 2025-3-22 10:16:58 | 显示全部楼层
Diagnosis and Management of Sickle Cell Disorders,xperience. This chapter brings together a detailed etiology, pathophysiology, and clinical presentation of SCD, including the differential diagnoses of pain associated with the disease, with evidence-based recommendations for pain management and the potential impact of low-molecular weight heparin (
发表于 2025-3-22 15:24:15 | 显示全部楼层
1064-3745 getting optimal results.Easy to use and up to date, Anticoagulants, Antiplatelets, and Thrombolytics, Second Edition is an ideal guide for researchers aiming for the future of this vital field, focusing on the978-1-4939-6097-2978-1-60761-803-4Series ISSN 1064-3745 Series E-ISSN 1940-6029
发表于 2025-3-22 20:58:54 | 显示全部楼层
发表于 2025-3-23 00:24:58 | 显示全部楼层
https://doi.org/10.1007/978-3-322-88746-7treatment of pulmonary embolism, secondary prevention after acute coronary syndromes, and the prevention of stroke and non-central nervous system embolism in patients with non-valvular atrial fibrillation. The need for new oral anticoagulants, the development and pharmacology of rivaroxaban, results
发表于 2025-3-23 03:54:46 | 显示全部楼层
https://doi.org/10.1007/978-3-658-28020-8t response, and faster onset of activity compared to clopidogrel. Recent findings from large-scale phase-III testing show prasugrel to be more efficacious in preventing ischemic events in acute coronary syndrome patients undergoing percutaneous coronary intervention (PCI); however, this is achieved
发表于 2025-3-23 07:40:31 | 显示全部楼层
,Vorstudie für Studien 2 und 3,d on the key role of CAMs, with special emphasis on integrins in various diseases, as well as the structure–function aspects of cell adhesion and signaling of the different CAMs and ECM are highlighted.
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-13 05:01
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表